2016 is almost over; a good time to reflect on our achievements this year. First, several grants have been awarded to our group (Hans Berkhof and Nienke Veldhuijzen: effects, costs and burden of risk-based cervical cancer screening and Veerle Coupé: personalised adjuvant treatment in early colon cancer). Furthermore, we presented our work at international conferences and published extensively in peer-reviewed, international journals. A selection of key publications can be found below. We look back on a great year and wish you all a merry Christmas and a successful 2017!
Papers published in 2016:
Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
Jansen F, Krebber AM, Coupé VM, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman AT, Leemans CR, Verdonck-de Leeuw IM.
J Clin Oncol. 2016. [Epub ahead of print]
Resilience of a FIT screening programme against screening fatigue: a modelling study.
Greuter MJ, Berkhof J, Canfell K, Lew JB, Dekker E, Coupé VM.
BMC Public Health. 2016;16(1):1009.
A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
Vink MA, Berkhof J, van de Kassteele J, van Boven M, Bogaards JA.
PLoS One. 2016 Aug 18;11(8):e0161109.
The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.
Greuter MJ, Berkhof J, Fijneman RJ, Demirel E, Lew JB, Meijer GA, Stoker J, Coupé VM.
Br J Radiol. 2016;89(1063):20150910.
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG, van Zummeren M, Rozendaal L, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ, Berkhof J.
BMJ. 2016 Oct 4;355:i4924.
Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
Greuter MJ, Demirel E, Lew JB, Berkhof J, Xu XM, Canfell K, Dekker E, Meijer GA, Coupé VM.
Cancer Epidemiol Biomarkers Prev. 2016;25(1):135-44.
The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.
van der Meijde E, van den Eertwegh AJ, Linn SC, Meijer GA, Fijneman RJ, Coupé VM.
Cancer Inform. 2016;15:115-27.
Costs of non-small cell lung cancer in the Netherlands.
van der Linden N, Bongers ML, Coupé VM, Smit EF, Groen HJ, Welling A, Schramel FM, Uyl-de Groot CA.
Lung Cancer. 2016;91:79-88.
Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity.
Bongers ML, de Ruysscher D, Oberije C, Lambin P, Uyl-de Groot CA, Coupé VM.
Med Decis Making. 2016;36(1):86-100.